| Namita Seth Mohta, | |
|
75 Francis St, Pbb-4 Suite 428, Room 429 (hospitalist Service), Boston, MA 02115-6110 | |
| (617) 732-5500 | |
| Not Available |
| Full Name | Namita Seth Mohta |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 75 Francis St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073607255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 227050 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
Scientists used fruit flies to show for the first time that a new class of genetically engineered proteins can be used to watch nerve cell electrical activity in live brains. The results, published in Cell, suggest these proteins may be a promising new tool for mapping brain cell activity in multiple animals and for studying how neurological disorders disrupt normal nerve cell signaling.
Exposure to endocrine-disrupting chemicals can cause health effects, such as reduced fertility and increased incidences of obesity and diabetes. Two decades ago, Congress directed the U.S. Environmental Protection Agency to screen substances for this activity.
The weirdest thing about the ongoing conniption about the cancellation of people's health insurance plans - supposedly as a result of Obamacare - is the notion that these are plans people liked, even loved. When did that happen? It wasn't so long ago - months, even weeks - when the health insurance companies were being roundly cursed for their ruthless mistreatment of individual health plan customers. Constant rate hikes. Cancellations after policyholders got sick. Endless hoops to jump through to file a claim or appeal a rejection (Michael Hiltzik, 10/31).
Children with severe epilepsy could be helped by a new treatment derived from the cannabis plant.
Idera Pharmaceuticals, Inc. today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled "A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis" (abstract P259) was made by Idera scientists at the American Heart Association conference "Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions" being held April 8-10 in San Francisco, CA.
› Verified 3 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Scientists used fruit flies to show for the first time that a new class of genetically engineered proteins can be used to watch nerve cell electrical activity in live brains. The results, published in Cell, suggest these proteins may be a promising new tool for mapping brain cell activity in multiple animals and for studying how neurological disorders disrupt normal nerve cell signaling.
Exposure to endocrine-disrupting chemicals can cause health effects, such as reduced fertility and increased incidences of obesity and diabetes. Two decades ago, Congress directed the U.S. Environmental Protection Agency to screen substances for this activity.
The weirdest thing about the ongoing conniption about the cancellation of people's health insurance plans - supposedly as a result of Obamacare - is the notion that these are plans people liked, even loved. When did that happen? It wasn't so long ago - months, even weeks - when the health insurance companies were being roundly cursed for their ruthless mistreatment of individual health plan customers. Constant rate hikes. Cancellations after policyholders got sick. Endless hoops to jump through to file a claim or appeal a rejection (Michael Hiltzik, 10/31).
Children with severe epilepsy could be helped by a new treatment derived from the cannabis plant.
Idera Pharmaceuticals, Inc. today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled "A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis" (abstract P259) was made by Idera scientists at the American Heart Association conference "Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions" being held April 8-10 in San Francisco, CA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Namita Seth Mohta, 3 Blackstone St, #3, Cambridge, MA 02139-3889 Ph: (617) 732-5500 | Namita Seth Mohta, 75 Francis St, Pbb-4 Suite 428, Room 429 (hospitalist Service), Boston, MA 02115-6110 Ph: (617) 732-5500 |
News Archive
Scientists used fruit flies to show for the first time that a new class of genetically engineered proteins can be used to watch nerve cell electrical activity in live brains. The results, published in Cell, suggest these proteins may be a promising new tool for mapping brain cell activity in multiple animals and for studying how neurological disorders disrupt normal nerve cell signaling.
Exposure to endocrine-disrupting chemicals can cause health effects, such as reduced fertility and increased incidences of obesity and diabetes. Two decades ago, Congress directed the U.S. Environmental Protection Agency to screen substances for this activity.
The weirdest thing about the ongoing conniption about the cancellation of people's health insurance plans - supposedly as a result of Obamacare - is the notion that these are plans people liked, even loved. When did that happen? It wasn't so long ago - months, even weeks - when the health insurance companies were being roundly cursed for their ruthless mistreatment of individual health plan customers. Constant rate hikes. Cancellations after policyholders got sick. Endless hoops to jump through to file a claim or appeal a rejection (Michael Hiltzik, 10/31).
Children with severe epilepsy could be helped by a new treatment derived from the cannabis plant.
Idera Pharmaceuticals, Inc. today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled "A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis" (abstract P259) was made by Idera scientists at the American Heart Association conference "Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions" being held April 8-10 in San Francisco, CA.
› Verified 3 days ago
Dr. Christine Martin, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-2687 | |
Jacob Koshy, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-754-4677 | |
Hien Le, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-3842 | |
Ms. Archana Vasudevan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-7399 Fax: 617-414-9201 | |
Lina M Ortega, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Zachary Hyde Strasser, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-7930 |